In this exercise the Company’s global sales increased 2.5% compared to 2015, reaching the amount of $11,316.3 million pesos. Mexico’s sales accounted for 41% of total sales for 2016, while Latin America and the United States accounted for 45% and 14% of total sales, respectively2, in line with the objective of further diversifying our operations to decrease dependence on Mexico.
For the fourth quarter of 2016, Mexico’s sales exceeded our expectations. They reached $ 1,315.3 million pesos, reporting an increase of 41.5% compared to the same period of the previous year.
Below, the Profit and Loss Statement of Genomma Lab S.A.B. De C.V. and its subsidiaries:
Source: Financial Statements audited by Deloitte.